The problem of cerebrovascular diseases prevention is currently urgent not only in neurology, but in the community as a whole, because of the leading rates of vascular diseases in population disability and mortality. Hypercholesterolemia is one of the corrected risk factors for the development of the given diseases. The results of the study of 109 patients with CBI, II-III stages, treated with the drug liprimar and a new physiotherapeutic device, the neutralizer of free radicals, for cholesterol level optimization are presented.